NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Michael Khan
University of Warwick - Coventry / United Kingdom
Others
AD Scientific Index ID: 1522589
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Michael Khan's MOST POPULAR ARTICLES
1-)
c-MYC: more than just a matter of life and deathS Pelengaris, M Khan, G EvanNature Reviews Cancer 2 (10), 764-776, 200213142002
2-)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ...The Lancet 385 (9965), 331-340, 20157792015
3-)
Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progressionS Pelengaris, M Khan, GI EvanCell 109 (3), 321-334, 20027772002
4-)
Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesionS Pelengaris, T Littlewood, M Khan, G Elia, G EvanMolecular cell 3 (5), 565-577, 19996091999
5-)
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidanceS Rabar, M Harker, N O’Flynn, AS WierzbickiBmj 349, 20143412014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept